Brewin Dolphin Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$3.96M Sell
18,875
-372
-2% -$79.2K 0.43% 40
2022
Q1
$4.67M Sell
19,247
-709
-4% -$171K 0.52% 38
2021
Q4
$5.2M Sell
19,956
-75
-0.4% -$19.5K 0.56% 38
2021
Q3
$5.28M Sell
20,031
-595
-3% -$163K 0.6% 38
2021
Q2
$5.08M Hold
20,626
0.62% 35
2021
Q1
$4M Sell
20,626
-1,069
-5% -$214K 0.61% 30
2020
Q4
$4.61M Hold
21,695
0.78% 27
2020
Q3
$3.72M Sell
21,695
-770
-3% -$142K 0.69% 29
2020
Q2
$4.31M Sell
22,465
-600
-3% -$98.2K 0.92% 23
2020
Q1
$3.4M Sell
23,065
-1,330
-5% -$212K 1.83% 16
2019
Q4
$3.78M Sell
24,395
-110
-0.4% -$15.9K 1.75% 19
2019
Q3
$3.31M Sell
24,505
-615
-2% -$80.6K 1.68% 19
2019
Q2
$3.07M Sell
25,120
-92
-0.4% -$10.2K 1.6% 19
2019
Q1
$2.62M Buy
25,212
+523
+2% +$54K 1.43% 21
2018
Q4
$2.81M Buy
24,689
+300
+1% +$32.1K 1.7% 20
2018
Q3
$2.81M Sell
24,389
-185
-0.8% -$20.3K 1.51% 21
2018
Q2
$2.55M Sell
24,574
-265
-1% -$26.8K 1.51% 21
2018
Q1
$2.45M Buy
24,839
+745
+3% +$70.4K 1.51% 21
2017
Q4
$2.04M Hold
24,094
1.3% 23
2017
Q3
$1.85M Buy
+24,094
New +$1.84M 1.29% 23

Other funds holding RMD

Brewin Dolphin Wealth Management's RMD Position: Q2 2022 in Review

Brewin Dolphin Wealth Management reduced its ResMed (RMD) stake by 1.9% in Q2 2022, selling an estimated $79.2K and leaving 18,875 shares worth $3.96M. The position accounts for 0.43% of the portfolio, ranked #40.

Brewin Dolphin Wealth Management first reported a position in RMD in Q3 2017 and has held it in 20 quarters since. The position peaked at $5.28M in Q3 2021. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • Brewin Dolphin Wealth Management held 18,875 shares of ResMed worth $3.96M as of Q2 2022.
  • Brewin Dolphin Wealth Management sold 372 ResMed shares in Q2 2022, an estimated $79.2K.
  • ResMed made up 0.43% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #40 holding.
  • Brewin Dolphin Wealth Management first reported a position in ResMed in Q3 2017 and has held it in 20 quarters since.
  • Brewin Dolphin Wealth Management's ResMed position peaked at $5.28M in Q3 2021.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.